ADENOSINE-DEAMINASE INHIBITORS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2-HYDROXY-3-NONYL DERIVATIVES OF AZOLES

被引:28
|
作者
CRISTALLI, G [1 ]
ELEUTERI, A [1 ]
VOLPINI, R [1 ]
VITTORI, S [1 ]
CAMAIONI, E [1 ]
LUPIDI, G [1 ]
机构
[1] UNIV CAMERINO,DIPARTIMENTO BIOL CELLULARE,I-62032 CAMERINO,ITALY
关键词
D O I
10.1021/jm00027a026
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of erythro-1-(2-hydroxy-3-nonyl)azole derivatives have been synthesized and evaluated for adenosine deaminase (ADA) inhibitory activity, in order to introduce simplifications in the ADA inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA, 1a). The synthesis of most of the reported compounds was achieved by reaction of 2-bromo-3-nonanone with the suitable azole followed by reduction of the carbonyl group to give a diastereoisomeric mixture of N-substituted (2-hydroxy-3-nonyl)azoles. Separation of diastereoisomers was achieved by HPLC or by preparative TLC plates. The results of the enzymatic test indicate that the nitrogen in the 3-position, and secondly, the nitrogen in the 5-position are very important for the interaction of the azole ring with the inhibitory site on the enzyme. In fact, the pyrazole and the 2-substituted 1,2,3-triazole derivatives (10 and 15, respectively) are nearly inactive, whereas the erythro-1-(2-hydroxy-3-nonyl)-1,2,4-triazole(18e) was the most potent ADA inhibitor in the series with K-i = 0.3 mu M.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 50 条
  • [1] ADENOSINE-DEAMINASE INHIBITORS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF IMIDAZOLE ANALOGS OF ERYTHRO-9-(2-HYDROXY-3-NONYL)ADENINE
    CRISTALLI, G
    ELEUTERI, A
    FRANCHETTI, P
    GRIFANTINI, M
    VITTORI, S
    LUPIDI, G
    JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (03) : 1187 - 1192
  • [2] ADENOSINE-DEAMINASE INHIBITORS - STRUCTURE-ACTIVITY-RELATIONSHIPS IN 1-DEAZAADENOSINE AND ERYTHRO-9-(2-HYDROXY-3-NONYL)ADENINE ANALOGS
    CRISTALLI, G
    ELEUTERI, A
    VITTORI, S
    VOLPINI, R
    CAMAIONI, E
    LUPIDI, G
    DRUG DEVELOPMENT RESEARCH, 1993, 28 (03) : 253 - 258
  • [3] INHIBITORS OF ADENOSINE-DEAMINASE - SYNTHESIS, ACTIVITIES AND STRUCTURE-ACTIVITY-RELATIONSHIPS
    BAKER, DC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1982, 184 (SEP): : 5 - CARB
  • [4] ADENOSINE-DEAMINASE INHIBITORS - SYNTHESIS OF DEAZA ANALOGS OF ERYTHRO-9-(2-HYDROXY-3-NONYL)ADENINE
    ANTONINI, I
    CRISTALLI, G
    FRANCHETTI, P
    GRIFANTINI, M
    MARTELLI, S
    LUPIDI, G
    RIVA, F
    JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (03) : 274 - 278
  • [5] ADENOSINE-DEAMINASE INHIBITORS - SYNTHESIS AND BIOLOGICAL-ACTIVITY OF DEAZA ANALOGS OF ERYTHRO-9-(2-HYDROXY-3-NONYL)ADENINE
    CRISTALLI, G
    FRANCHETTI, P
    GRIFANTINI, M
    VITTORI, S
    LUPIDI, G
    RIVA, F
    BORDONI, T
    GERONI, C
    VERINI, MA
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (02) : 390 - 393
  • [6] ADENOSINE-DEAMINASE INHIBITORS - CONVERSION OF A SINGLE CHIRAL SYNTHON INTO ERYTHRO-9-(2-HYDROXY-3-NONYL) ADENINE AND THREO-9-(2-HYDROXY-3-NONYL)ADENINE
    BASTIAN, G
    BESSODES, M
    PANZICA, RP
    ABUSHANAB, E
    CHEN, SF
    STOECKLER, JD
    PARKS, RE
    JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (12) : 1383 - 1385
  • [7] KINETICS OF INHIBITION OF CALF INTESTINAL ADENOSINE-DEAMINASE BY (+)-ERYTHRO-9-(2-HYDROXY-3-NONYL)ADENINE AND (-)-ERYTHRO-9-(2-HYDROXY-3-NONYL)ADENINE
    PORTER, DJT
    ABUSHANAB, E
    BIOCHEMISTRY, 1992, 31 (35) : 8216 - 8220
  • [8] INHIBITION OF BRAIN ADENOSINE-DEAMINASE BY 2'-DEOXYCOFORMYCIN AND ERYTHRO-9-(2-HYDROXY-3-NONYL) ADENINE
    SKOLNICK, P
    NIMITKITPAISAN, Y
    STALVEY, L
    DALY, JW
    JOURNAL OF NEUROCHEMISTRY, 1978, 30 (06) : 1579 - 1582
  • [9] EFFECT OF CHIRALITY IN ERYTHRO-9-(2-HYDROXY-3-NONYL)ADENINE (EHNA) ON ADENOSINE-DEAMINASE INHIBITION
    BESSODES, M
    BASTIAN, G
    ABUSHANAB, E
    PANZICA, RP
    BERMAN, SF
    MARCACCIO, EJ
    CHEN, SF
    STOECKLER, JD
    PARKS, RE
    BIOCHEMICAL PHARMACOLOGY, 1982, 31 (05) : 879 - 882
  • [10] Adenosine deaminase inhibitors: Synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide
    Volpini, R
    Camaioni, E
    Lupidi, G
    Vittori, S
    Cristalli, G
    FARMACO, 1997, 52 (6-7): : 429 - 433